• Catalog Number:

  E1A0583A-2

• Amount:

  50ul

• Form of Antibody:

  Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

• Storage/Stability:

  Store at -20℃/1 year

• class="eg_cn_title"Immunogen:

  The antiserum was produced against synthesized phosphopeptide derived from human TEBP around the phosphorylation site of serine 113 (D-D-SP-D-E).

• Purification:

  The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.

• Reactivity:

  Human, Mouse, Rat

• SwissProtNo:

  Q15185

• Applications:

  WB: 1:500~1:1000 IHC: 1:50~1:100 ELISA: 1:1000

• Other Names:

  EC 5.3.99.3, Hsp90 co-chaperone, P23, PGE synthase, cytosolic, PTGES3, Progesterone receptor complex p23, cPGES

• Specificity Sensitivity:

  TEBP (Phospho-Ser113) antibody detects endogenous levels of TEBP only when phosphorylated at serine 113.

• References:

  Hidenori Oguchi, Endocrinology, Apr 1998; 139: 1999. Takashi Kusakabe, Mol. Endocrinol., Aug 2006; 20: 1796 - 1809. K Mizuno, Mol. Cell. Biol., Oct 1991; 11: 4927 - 4933. S Kimura, Genes & Dev., Jan 1996; 10: 60 - 69.

• All Sites:

  Human: Ser113; Mouse: Ser113; Rat: Ser245

P-peptide - +

Immunohistochemistry analysis of paraffin-embedded human colon carcinoma tissue using TEBP (Phospho-Ser113) antibody. Western blot analysis of extracts from NIH/3T3 cells, treated with EGF (200ng/ml, 30mins), using TEBP (Phospho-Ser113) antibody.